| Gene Set | Leading Edge Genes |
|---|
| SPIELMAN LYMPHOBLAST EUROPEAN VS ASIAN UP | KIF20A, HDAC1, ATP5I, NDUFA3, ATP5G2, NDUFB8, POLR2I, CSNK1G2, GPX1, TUBB3, UBL5, EI24, ICMT, HMGB3, NDUFS8, BLOC1S1, CENPF, DBI, PFN1, UQCRC1, DCXR, MBD3, TUBB, UBE2C, CST3, BCAT2, ATP5J2, ATP5J, HSPB1, KIF22, PPIB, DDT, COX6C, DPYSL2, HMBS, EBP, NDUFV2, RTN3, SCAND1, TSPAN3, NUDT3, H2AFX, HMGB1, PRDX2, FKBP2, ETV5, CACYBP, ATP5G3, NONO, H2AFV, TACC3, MORF4L2, PSMB3, DHCR7, ERH |
| KEGG ALZHEIMERS DISEASE | CALM3, NDUFA3, ATP5G2, NDUFB8, UQCRH, CAPN2, MAPK3, ADAM10, UQCRFS1, NDUFS8, NDUFA8, CALM2, NDUFB3, ATP5A1, ATP5J, NDUFA4, ATP5E, ATP5G3, COX7A2L, COX6C, COX7C, NDUFC1 |
| ACEVEDO LIVER TUMOR VS NORMAL ADJACENT TISSUE UP | SET, SEC61B, RPS25, ILF2, CETN2, MGST3, CHPT1, COPE, NRAS, DYNLRB1, SDF2L1, TFIP11, BLVRA, ICT1, NDUFA8, THAP11, PFN1, APEX1, WRB, PDIA6, RNASEH2A, TK1, GOLPH3L, COPB2, SURF1, ASPM, CD9, GNPAT, MRPL40, MAPRE1, PPP1CA, CCNA2, WDR8, NDUFB3, GMNN, MSH6, IDH1, TUBB2C, RPA1, VPS28, TFG |
| NUYTTEN EZH2 TARGETS DN | KIF20A, SET, ORMDL2, GMPR2, TMPO, PRPS2, PLK1, CCNB1, THOP1, GLT8D1, CENPA, MRPS33, AURKB, SYPL1, HMGB3, CENPF, CDCA3, DAZAP2, FIBP, SLC29A1, UBE2C, RNASEH2A, HMBS, ASPM, NDUFV2, GEMIN4, DDHD2, GNPAT, CMAS, RAC1, TMEM48, H2AFX, GALK2, HMGB1, CCNA2, CENPJ, RACGAP1, GMNN, CCNB2, PIGP, TPX2, FADS1, TSN, MBTPS1, H2AFV, TACC3, NT5DC2, KIF2C, BIRC5 |
| BORCZUK MALIGNANT MESOTHELIOMA UP | BUB1B, SLC25A3, SCCPDH, ILF2, PRDX4, PRPS2, CCNB1, CCNG1, BLVRA, MAPRE1, THAP11, DBI, ATP5A1, MSH6, TPX2, CNOT8, UBE2C, CCT5, FADS1, MAGED2, GLO1, H2AFV, TK1, RAB4A, DDOST, MORF4L2, RPA1 |
| NCI TRANSFORMATION OF LANOSTEROL TO CHOLESTEROL | |
| REACTOME CELL CYCLE MITOTIC | |
| KEGG CITRATE CYCLE TCA CYCLE | |
| GRADE COLON CANCER UP | |
| REACTOME REGULATION OF APC ACTIVATORS BETWEEN G1 S AND EARLY ANAPHASE | |
| MONTERO THYROID CANCER POOR SURVIVAL UP | |
| BENPORATH CYCLING GENES | |
| BHATTACHARYA EMBRYONIC STEM CELL | |
| GRADE METASTASIS DN | |
| ALONSO METASTASIS UP | |
| YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 12 | |
| PAL PRMT5 TARGETS UP | |
| ODONNELL TARGETS OF MYC AND TFRC DN | |
| STEIN ESRRA TARGETS | |
| NCI PLK1 PATHWAY | |
| KEGG PARKINSONS DISEASE | |
| MARKEY RB1 CHRONIC LOF UP | |
| SANA RESPONSE TO IFNG DN | |
| KEGG HUNTINGTONS DISEASE | |
| CORUM F1F0-ATP SYNTHASE EC 3.6.3.14 MITOCHONDRIAL | |
| BUYTAERT PHOTODYNAMIC THERAPY STRESS DN | |
| REACTOME INTEGRATION OF ENERGY METABOLISM | |
| LOPEZ MBD TARGETS | |
| MODY HIPPOCAMPUS PRENATAL | |
| NCI APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | |
| KAYO AGING MUSCLE DN | |
| LEE LIVER CANCER SURVIVAL DN | |
| KEGG PROPANOATE METABOLISM | |
| MUELLER PLURINET | |
| NCI APC CDC20 MEDIATED DEGRADATION OF NEK2A | |
| DAIRKEE TERT TARGETS UP | |
| STEIN ESRRA TARGETS UP | |
| RICKMAN TUMOR DIFFERENTIATED WELL VS POORLY UP | |
| POMEROY MEDULLOBLASTOMA PROGNOSIS DN | |
| FINETTI BREAST CANCER BASAL VS LUMINAL | |
| KAAB FAILED HEART ATRIUM DN | |
| REACTOME REGULATION OF INSULIN SECRETION | |
| CHAUHAN RESPONSE TO METHOXYESTRADIOL DN | |
| CASORELLI ACUTE PROMYELOCYTIC LEUKEMIA DN | |
| CORUM CTCF-NUCLEOPHOSMIN-PARP-HIS-KPNA-LMNA-TOP COMPLEX | |
| LI AMPLIFIED IN LUNG CANCER | |
| REACTOME CHOLESTEROL BIOSYNTHESIS | |
| REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | |
| PENG LEUCINE DEPRIVATION DN | |
| UDAYAKUMAR MED1 TARGETS UP | |
| ACEVEDO NORMAL TISSUE ADJACENT TO LIVER TUMOR DN | |
| FINETTI BREAST CANCER KINOME RED | |
| OUELLET CULTURED OVARIAN CANCER INVASIVE VS LMP UP | |
| PENG GLUTAMINE DEPRIVATION DN | |
| NCI FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | |
| KEGG PYRUVATE METABOLISM | |
| REACTOME TRANSFORMATION OF LANOSTEROL TO CHOLESTEROL | |
| CAIRO HEPATOBLASTOMA UP | |
| TAKAO RESPONSE TO UVB RADIATION UP | |
| GOLDRATH ANTIGEN RESPONSE | |